These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 21319056)

  • 21. Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study.
    Ghiasi M; Daneshpazhooh M; Ismonov M; Chams-Davatchi C
    Skinmed; 2017; 15(3):175-180. PubMed ID: 28705276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bullous pemphigoid with pemphigus type antibodies in vivo. 2 cases].
    Bernard P; Catanzano G; Vignaud St Florent JD; Fayol J; Bonnetblanc JM
    Ann Dermatol Venereol; 1986; 113(8):671-6. PubMed ID: 3541760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignancies in pemphigus and pemphigoid diseases.
    Schulze F; Neumann K; Recke A; Zillikens D; Linder R; Schmidt E
    J Invest Dermatol; 2015 May; 135(5):1445-1447. PubMed ID: 25560279
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased serum levels of circulating CD40 ligand in patients with bullous pemphigoid: preliminary results.
    Watanabe R; Ishiura N; Nakashima H; Yazawa N; Kuwano Y; Tada Y; Okochi H; Fujimoto M; Tamaki K
    Dermatology; 2007; 215(3):180-6. PubMed ID: 17823512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pemphigus-pemphigoid mixed bullous dermatosis in chronic lymphatic leukemia].
    Aloi FG; Colonna SM; Bernengo MG
    G Ital Dermatol Venereol; 1986; 121(5):343-8. PubMed ID: 3539773
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunopathology of pemphigus vulgaris, bullous pemphigoid and related bullous dermatoses.
    Patel HP; Anhalt GJ; Provost TT; Diaz LA
    Clin Immunol Rev; 1983-1984; 2(2):157-86. PubMed ID: 6370527
    [No Abstract]   [Full Text] [Related]  

  • 28. Epidemiological and clinical analysis of pemphigoid patients in northeastern Poland in 2000-2005.
    Serwin AB; Bokiniec E; Piascik M; Masny D; Chodynicka B
    Med Sci Monit; 2007 Aug; 13(8):CR360-4. PubMed ID: 17660726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid.
    Mabrouk D; Gürcan HM; Keskin DB; Christen WG; Ahmed AR
    Ann Pharmacother; 2010 Nov; 44(11):1770-6. PubMed ID: 20923942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study.
    Chen YJ; Wu CY; Lin MW; Chen TJ; Liao KK; Chen YC; Hwang CY; Chu SY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
    Br J Dermatol; 2011 Sep; 165(3):593-9. PubMed ID: 21517800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune blistering diseases in the elderly.
    Parker SR; MacKelfresh J
    Clin Dermatol; 2011; 29(1):69-79. PubMed ID: 21146735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pruritus Is Associated with an Increased Risk for the Diagnosis of Autoimmune Skin Blistering Diseases: A Propensity-Matched Global Study.
    Raap U; Limberg MM; Kridin K; Ludwig RJ
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bullous pemphigoid associated with renal cell carcinoma and invasive squamous cell carcinoma.
    Patel M; Sinha AA; Gilbert E
    J Drugs Dermatol; 2012 Feb; 11(2):234-8. PubMed ID: 22270209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.
    Bernard P; Vaillant L; Labeille B; Bedane C; Arbeille B; Denoeux JP; Lorette G; Bonnetblanc JM; Prost C
    Arch Dermatol; 1995 Jan; 131(1):48-52. PubMed ID: 7826096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune bullous dermatoses: a review.
    Patrício P; Ferreira C; Gomes MM; Filipe P
    Ann N Y Acad Sci; 2009 Sep; 1173():203-10. PubMed ID: 19758152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute zoster in known pemphigus vulgaris and bullous pemphigoid: avoiding the "disease flare" trap.
    Stevenson ML; Levitt JO
    J Am Acad Dermatol; 2011 Jun; 64(6):e125-6. PubMed ID: 21571161
    [No Abstract]   [Full Text] [Related]  

  • 37. Associations of pemphigus or pemphigoid with autoimmune disorders in US adult inpatients.
    Narla S; Silverberg JI
    J Am Acad Dermatol; 2020 Mar; 82(3):586-595. PubMed ID: 31319089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of a survey of German dermatologists on the therapeutic approaches to pemphigus and bullous pemphigoid.
    Hofmann SC; Kautz O; Hertl M; Sticherling M; Zillikens D; Bruckner-Tuderman L
    J Dtsch Dermatol Ges; 2009 Mar; 7(3):227-33. PubMed ID: 19371245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexist.
    Shiohara J; Yoshida K; Hasegawa J; Uhara H; Takata M; Saida T; Ohyama B; Hashimoto T
    J Dermatol; 2010 Jul; 37(7):657-61. PubMed ID: 20629832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of pemphigus and pemphigoid with osteoporosis and pathological fractures.
    Chovatiya R; Silverberg JI
    Arch Dermatol Res; 2020 May; 312(4):263-271. PubMed ID: 31741052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.